SparingVision announces to be Winner and Grand Prix of the i-LAB 2017 French National Competition for Innovative Companies

FFB and French Team Create IRD Treatment Biotech – Win Innovation Prize FINAL







The Foundation Fighting Blindness Clinical Research Institute (FFB-CRI), Bpifrance (Trough Biotechnology Accleration Fund & Innovative Biotherapies & Rare Diseases Fund set by the French national program « Investments for the future », and the Foundation Voir & Entendre (FVE) have invested in SparingVision: a total of € 15.5 million in SparingVIsion